Business News›Mutual Funds›ICICI Prudential Mutual Fund › ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
ICICI Prudential Pharma Healthcare and Diagnostics...
(Scheme Rating)
NAV as of Jun 12, 2026
45.090.87%
- Growth - Direct
(Earn upto 0.79% Extra Returns with Direct Plan)
Fund Category:
Equity: Sectoral-Pharma
Expense Ratio:
1.32%(0.86% Category
average)Fund Size:
Rs. 6,453.52 Cr(18.05% of Investment in Category)
Loading...
ICICI Prudential Pharma Healthcare and Diagnostics (P.H....
(Scheme Rating)
NAV as of Jun 12, 2026
45.090.87%
Expense Ratio:
1.32%
Fund Size:
Rs. 6,453.52 Cr
Fund Category:
Equity: Sectoral-Pharma
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth Fund Key Highlights
1. Current NAV: The Current Net Asset Value of the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan as of Jun 12, 2026 is Rs 45.09 for Growth option of its Direct plan.
2. Returns: Its trailing returns over different time periods are: 6.27% (1yr), 27.79% (3yr), 16.17% (5yr) and 20.94% (since launch). Whereas, Category returns for the same time duration are: 9.63% (1yr), 23.51% (3yr) and 13.16% (5yr).
3. Fund Size: The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan currently holds Assets under Management worth of Rs 6453.52 crore as on May 31, 2026.
4. Expense ratio: The expense ratio of the fund is 1.32% for Direct plan as on Jun 11, 2026.
5. Exit Load: ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan shall attract an Exit Load, "Exit load of 1% if redeemed within 15 days."
6. Minimum Investment: Minimum investment required is Rs 5000 and minimum additional investment is Rs 1000. Minimum SIP investment is Rs 100.
1. Current NAV: The Current Net Asset Value of the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan as of Jun 12, 2026 is Rs 45.09 for Growth option of its Direct plan.
2. Returns: Its trailing returns over different time periods are: 6.27% (1yr), 27.79% (3yr), 16.17% (5yr) and 20.94% (since launch). Whereas, Category returns for the same time duration are: 9.63% (1yr), 23.51% (3yr) and 13.16% (5yr).
3. Fund Size: The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan currently holds Assets under Management worth of Rs 6453.52 crore as on May 31, 2026.
4. Expense ratio: The expense ratio of the fund is 1.32% for Direct plan as on Jun 11, 2026.
5. Exit Load: ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan shall attract an Exit Load, "Exit load of 1% if redeemed within 15 days."
6. Minimum Investment: Minimum investment required is Rs 5000 and minimum additional investment is Rs 1000. Minimum SIP investment is Rs 100.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth Returns
Trailing Returns
Rolling Returns
Discrete Period
SIP Returns
1M 3M 6M 1Y 3Y 5Y Annualized Returns 1.37 8.89 4.04 6.27 27.79 16.17 Category Avg 2.74 8.22 7.50 9.63 23.51 13.16 Rank within Category 25 15 23 19 1 2 No. of funds within Category 33 33 30 27 17 12 - Loading...
- Loading...
Return Comparison
- This Fund
- BenchmarkS&P BSE Sensex
Choose from Benchmarks
- Nifty 50
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth Fund Details
Investment Objective - The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
| Fund House | ICICI Prudential Mutual Fund |
| Launch Date | Jul 13, 2018 |
| Benchmark | |
| Return Since Launch | 20.94% |
| Riskometer | Very High |
| Type | Open-ended |
| Risk Grade | Average |
| Return Grade | High |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth Investment Details
| Minimum Investment (Rs.) | 5,000.00 |
| Minimum Additional Investment (Rs.) | 1,000.00 |
| Minimum SIP Investment (Rs.) | 100.00 |
| Minimum Withdrawal (Rs.) | 1.00 |
| Exit Load Exit load of 1% if redeemed within 15 days. | |
Portfolio Allocation
Asset Allocation
Loading...
Asset Allocation History
Loading...
EquityDebtCash
Sector Allocation
Loading...
Market Cap Allocation
Loading...
Concentration & Valuation Analysis
| MAY 2026 | APR 2026 | MAR 2026 | FEB 2026 | JAN 2026 | DEC 2025 | |
|---|---|---|---|---|---|---|
| Number of Holdings | 37 | 38 | 39 | 40 | 41 | 39 |
| Top 5 Company Holdings | 40.33% | 39.49% | 40.4% | 40.97% | 40.46% | 41.31% |
| Top 10 Company Holdings | 60.71% | 60.15% | 60.74% | 61.24% | 60.91% | 61.93% |
| Company with Highest Exposure | Sun Pharmaceutical Industries (12.09%) | Sun Pharmaceutical Industries (11.76%) | Sun Pharmaceutical Industries (12.11%) | Sun Pharmaceutical Industries (11.21%) | Sun Pharmaceutical Industries (11.2%) | Sun Pharmaceutical Industries (12.05%) |
| Number of Sectors | 3 | 3 | 3 | 3 | 3 | 3 |
| Top 3 Sector Holdings | 99.82% | 96.76% | 97.62% | 97.98% | 97.6% | 97.87% |
| Top 5 Sector Holdings | 99.82% | 96.76% | 97.62% | 97.98% | 97.6% | 97.87% |
| Sector with Highest Exposure | Healthcare (97.25%) | Healthcare (94.36%) | Healthcare (95.42%) | Healthcare (95.5%) | Healthcare (95.07%) | Healthcare (95.07%) |
Top Stock Holdings
Sector Holdings in MF
Company Sector Assest(%) P/E EPS-TTM(₹) RETURN 1 YR(%) Sun Pharmaceutical Industries Healthcare 12.09 - - 0.33 Dr. Reddy's Laboratories Healthcare 7.7 - - 1.76 Cipla Healthcare 7.45 - - -0.70 Mankind Pharma Healthcare 7.03 - - -0.55 Divi's Laboratories Healthcare 6.06 - - - Biocon Healthcare 4.71 - - -1.10 Suven Pharmaceuticals Healthcare 4.37 - - -0.07 Alkem Laboratories Healthcare 4.08 - - 0.84 Medplus Health Services Healthcare 3.86 - - 0.49 Max Healthcare Institute Healthcare 3.36 - - -
Peer Comparison
Cumulative Returns
SIP returns
Discrete Returns
Quant Measures
Asset Allocation
Scheme Name NAV(Rs./Unit) Scheme Rating AUM(Rs. Cr) 1M 1Y 3Y 5Y ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth 45.09 6,453.52 1.37 6.27 27.79 16.17 SBI Healthcare Opportunities Fund Direct Plan-Growth 545.63 4,565.95 3.74 11.79 26.49 16.59 UTI Healthcare Fund Direct-Growth 355.96 1,216.85 4.41 10.95 27.77 15.08 Nippon India Pharma Fund Direct-Growth 604.70 8,635.75 1.56 5.59 23.28 13.34 Tata India Pharma & Healthcare Fund Direct-Growth 37.02 1,386.99 1.53 6.32 24.05 14.60
Risk Ratios
Ratios are calculated using the calendar month returns for the last 3 years
Standard Deviation
Standard Deviation
Standard deviation is the deviation of the fund's return around mean.
High Volatality
16.87VS16.03Fund Vs Category Avg
Beta
Beta
Beta shows the portfolio risk in relation to the market. A beta of less than 1 means that the fund returns are less volatile compared to the broader market. A beta of more than 1 means that the fund returns are more volatile than the broader markets. A beta equal to 1 means that fund's volatility is in line with the broader market.
High Volatality
0.96VS0.91Fund Vs Category Avg
Sharpe Ratio
Sharpe Ratio
Sharpe ratio is a risk adjusted performance measure. A fund with a higher Sharpe ratio is considered better than a fund with a lower Sharpe ratio.
Better risk-adjusted returns
1.23VS1.11Fund Vs Category Avg
Treynor's Ratio
Treynor's Ratio
Treynor is a risk adjusted performance measure. A fund with a higher Treynor ratio is considered better than a fund with a lower Treynor ratio.
Better risk-adjusted returns
21.59VS19.60Fund Vs Category Avg
Jensen's Alpha
Jensen's Alpha
Alpha shows the ability of the fund manager to outperform the market. A higher Alpha is preferred.
Better risk-adjusted returns
2.44VS0.43Fund Vs Category Avg
Mean Return
Mean Return
Average return generated by the fund during a specified period.
Better average monthly returns
26.65VS23.66Fund Vs Category Avg
Risk Ratio Chart
Loading...
- Risk Ratio
- Category Average
Size of Bubbles represents the Fund Size
ICICI Prudential Mutual Fund News
- Private sector banks are the best contrarian bet for the next 3 years, says S Naren
- ICICI Prudential Mutual Fund restricts subscription in ICICI Prudential Gold ETF
- MF Tracker: Can ICICI Prudential Multicap Fund sustain its strong track record in a volatile market?
- Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers
Fund Manager
- D.K.Dharmesh KakkadSince May 20207 schemes
Mr. kakkad is B.com., CA & CFA. He is associated with ICICI Prudential Asset Management Company Limited from June 2010. Prior to working in Dealing function, he was working in the Operations Department of ICICI Prudential AMC.
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y ICICI Prudential Value Direct-Growth Value Oriented 502.83 58,954.43 -1.77 ICICI Prudential Diversified Equity All Cap Omni FoF Direct - Growth Flexi Cap 31.54 307.17 -0.26 ICICI Prudential Equity Savings Fund Direct-Growth Equity Savings 24.76 16,732.92 2.87 ICICI Prudential Diversified Equity All Cap Active FoF Direct-Growth Flexi Cap 10.46 Unrated 761.09 - ICICI Prudential Aggressive Hybrid Active FoF Direct-Growth Aggressive Hybrid 235.37 Unrated 9,090.64 -1.52 ICICI Prudential Dynamic Asset Allocation Active FoF Direct-Growth Dynamic Asset Allocation 135.72 Unrated 28,240.83 2.45 ICICI Prudential Multi Sector Passive FoF Direct-Growth Thematic 173.74 Unrated 224.48 2.51
More ICICI Prudential Mutual Fund
| Scheme Name | Rating | Asset Size(Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| ICICI Prudential Multi Asset Fund Direct-Growth | 83,547.35 | -2.34 | -0.60 | -1.81 | 4.99 | 16.96 | |
| ICICI Prudential Large Cap Fund Direct-Growth | 76,296.98 | -3.77 | -3.87 | -8.90 | -5.05 | 13.43 | |
| ICICI Prudential Balanced Advantage Direct-Growth | 70,569.60 | -2.41 | -0.67 | -2.43 | 2.38 | 11.57 | |
| ICICI Prudential Value Direct-Growth | 58,954.43 | -3.39 | -4.34 | -9.03 | -3.93 | 16.06 | |
| ICICI Prudential Liquid Fund Direct Plan-Growth | 58,095.62 | 0.56 | 1.74 | 3.23 | 6.21 | 6.96 | |
| ICICI Prudential Equity & Debt Fund Direct-Growth | 50,032.71 | -3.24 | -1.56 | -3.88 | 0.65 | 16.03 | |
| ICICI Prudential India Opportunities Fund Direct - Growth | 36,478.25 | -3.21 | -2.42 | -5.73 | -1.59 | 19.00 | |
| ICICI Prudential Arbitrage Direct-Growth | 32,260.19 | 0.55 | 1.66 | 3.20 | 6.43 | 7.49 | |
| ICICI Prudential Corporate Bond Fund Direct Plan -Growth | 31,739.50 | 0.83 | 1.41 | 2.59 | 5.53 | 7.61 | |
| ICICI Prudential Money Market Direct-Growth | 30,335.00 | 0.48 | 1.52 | 2.93 | 6.03 | 7.32 |
Mutual Fund Tools
Top AMCs
- SBI Mutual Fund
- ICICI Prudential Mutual Fund
- HDFC Mutual Fund
- Nippon India Mutual Fund
- Kotak Mahindra Mutual Fund
- Aditya Birla Sun Life Mutual Fund
- UTI Mutual Fund
- Axis Mutual Fund
- Tata Mutual Fund
- DSP Mutual Fund
- Mirae Asset Mutual Fund
- Bandhan Mutual Fund
- Edelweiss Mutual Fund
- PPFAS Mutual Fund
- Invesco Mutual Fund
About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
1. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan is Open-ended Sectoral-Pharma Equity scheme which belongs to ICICI Prudential Mutual Fund House.
2. The fund was launched on Jul 13, 2018.
Investment objective & Benchmark
1. The investment objective of the fund is that " The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. "
2. It is benchmarked against null.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 99.82% in equities, 0.0% in debts and 0.18% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 60.71% of the assets, the top 3 sectors constitute around 99.82% of the assets.
3. The fund largely follows a Growth oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.
1. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan is Open-ended Sectoral-Pharma Equity scheme which belongs to ICICI Prudential Mutual Fund House.
2. The fund was launched on Jul 13, 2018.
Investment objective & Benchmark
1. The investment objective of the fund is that " The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. "
2. It is benchmarked against null.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 99.82% in equities, 0.0% in debts and 0.18% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 60.71% of the assets, the top 3 sectors constitute around 99.82% of the assets.
3. The fund largely follows a Growth oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.
This Might Catch Your Interest
FAQs about ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
- Is it safe to invest in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan?As per SEBI’s latest guidelines to calculate risk grades, investment in the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan comes under Very High risk category.
- What is the category of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan?ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan belongs to the Equity : Sectoral-Pharma category of funds.
- How Long should I Invest in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan?The suggested investment horizon of investing into ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan is >3 years. The suggested investment horizon is the minimum time required for holding investments in the fund to reduce its downside risk and ensure that the returns become more predictable.
- Who manages the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan?The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan is managed by Priyanka Khandelwal (Since Jun 25, 2018) and Dharmesh Kakkad (Since May 02, 2020).
Date Sources: Mutual Funds, ETFs, and NPS data are sourced from Value Research. All times stamps are reflecting IST (Indian Standard Time). By using this site, you agree to the Terms of Service and Privacy Policy.
